Selvita SA (SLV):企業の財務・戦略的SWOT分析

◆英語タイトル:Selvita SA (SLV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH248860FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Selvita SA (Selvita) is a clinical stage biopharmaceutical company that develops small molecule therapies for the treatment of cancer. It is evaluating its pipeline candidates including SEL120, a selective CDK8 kinase inhibitor for the treatment of hematological malignancies and solid tumors; and SEL24/MEN1703, a dual PIM/FLT3 kinase inhibitor for the treatment of acute myeloid leukemia. Selvita is also investigating various pre-clinical immuno-oncology candidates and candidates based on synthetic lethality for the treatment of solid tumors. The company has collaborations with Lund University, Jagiellonian University, Cancer Center and Institute of Oncology, and Institute of Hematology and Blood Transfusion (IHT). Selvita is headquartered in Krakow, Lesser Poland, Poland.

Selvita SA Key Recent Developments

Mar 30,2021: Breakthrough year in the development of Selvita – strategic acquisition & strong financial results
Feb 09,2021: Selvita develops the cell-based phenotypic assay platform for drug discovery
Nov 19,2020: 19/11/20 Ryvu Therapeutics Reports Q3 2020 Financial Results Read more
Sep 10,2020: Selvita reports strong financial results for H1 2020 and a record backlog

This comprehensive SWOT profile of Selvita SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Selvita SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Selvita SA – Key Information
Selvita SA – Overview
Selvita SA – Key Employees
Selvita SA – Key Employee Biographies
Selvita SA – Key Operational Heads
Selvita SA – Major Products and Services
Selvita SA – History
Selvita SA – Company Statement
Selvita SA – Locations And Subsidiaries
Selvita SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Selvita SA – Business Description
Selvita SA – Corporate Strategy
Selvita SA – SWOT Analysis
SWOT Analysis – Overview
Selvita SA – Strengths
Selvita SA – Weaknesses
Selvita SA – Opportunities
Selvita SA – Threats
Selvita SA – Key Competitors

Section 3 – Company Financial Performance Charts

Selvita SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Selvita SA, Key Information
Selvita SA, Key Ratios
Selvita SA, Share Data
Selvita SA, Major Products and Services
Selvita SA, History
Selvita SA, Key Employees
Selvita SA, Key Employee Biographies
Selvita SA, Key Operational Heads
Selvita SA, Other Locations
Selvita SA, Subsidiaries
Selvita SA, Key Competitors
Selvita SA, SWOT Analysis
Selvita SA, Ratios based on current share price
Selvita SA, Annual Ratios
Selvita SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Selvita SA (SLV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Royal FrieslandCampina N.V.:企業のM&A・事業提携・投資動向
    Royal FrieslandCampina N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal FrieslandCampina N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Bank Of Cyprus Public Company Ltd
    Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Andromeda Metals Ltd (ADN):企業の財務・戦略的SWOT分析
    Summary Andromeda Metals Ltd (Andromeda), formerly Adelaide Resources Ltd, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration and development of gold, halloysite-kaolin, lithium, and copper deposits in Australia. Its projects include Moonta …
  • Klabin SA:企業の戦略・SWOT・財務情報
    Klabin SA - Strategy, SWOT and Corporate Finance Report Summary Klabin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Standard Chartered Bank Kenya Ltd:企業の戦略・SWOT・財務分析
    Standard Chartered Bank Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Bank Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • TVS Motor Co Ltd:戦略・SWOT・企業財務分析
    TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kumagai Gumi Co., Ltd.:企業の戦略・SWOT・財務分析
    Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Colas SA (RE):企業の財務・戦略的SWOT分析
    Colas SA (RE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • CanBas Co Ltd (4575)-製薬・医療分野:企業M&A・提携分析
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that provides drugs. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It product under development is CBP501, a modified synthetic peptide enhancing the efficacy of …
  • Cellmid Ltd (CDY):医療機器:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Lyft Inc (LYFT):企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • ESSA Pharma Inc (EPI)-製薬・医療分野:企業M&A・提携分析
    Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional acti …
  • Exosomics Siena SpA:企業の製品パイプライン分析2018
    Summary Exosomics Siena SpA (Exosomics Siena) is a biotechnology company that offers research and development services. The company provides services such as contract research, collaborative project management, lead development and technological services. It offers technological services such as sam …
  • AiCuris GmbH & Co KG-製薬・医療分野:企業M&A・提携分析
    Summary AiCuris GmbH & Co KG (AiCuris), a subsidiary of Santo Holding AG is a drug development company that discovers and develops antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. The company’s pipeline products include antiviral and antibacterial agents …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務情報
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Taiwan Semiconductor Manufacturing Company Limited:企業の戦略・SWOT・財務情報
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Awarepoint Corp-医療機器分野:企業M&A・提携分析
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that offers real time location system. The company provides technology, software and managed services. It offers location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patient …
  • Hyundai Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • QT Vascular Ltd (5I0):医療機器:M&Aディール及び事業提携情報
    Summary QT Vascular Ltd (QT Vascular) is a medical device manufacturing company that offers developing, manufacturing and distributing of advanced therapeutic solutions for the treatment of complex vascular diseases. The company’s products include coronary products such as Chocolate PTCA Balloon Cat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆